| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/30/2011 | US20110158993 Train-R: A Cysteine Rich Member of the TNF-Receptor Family |
| 06/30/2011 | US20110158992 Engineered Anti-IL-23R Antibodies |
| 06/30/2011 | US20110158991 Cytotoxic agents comprising new maytansinoids |
| 06/30/2011 | US20110158990 5-anilinoimidazopyridines and methods of use |
| 06/30/2011 | US20110158989 Poly (ADP-Ribose) Polymerase (PARP) INHIBITORS |
| 06/30/2011 | US20110158988 Antibodies against extracellular domains 2 and 3 or her2 |
| 06/30/2011 | US20110158987 Novel antibody formulation |
| 06/30/2011 | US20110158986 Humanized antibodies that sequester amyloid beta peptide |
| 06/30/2011 | US20110158985 Methods of preventing and treating rsv infections and related conditions |
| 06/30/2011 | US20110158984 Anti-orthopoxvirus recombinant polyclonal antibody |
| 06/30/2011 | US20110158983 Compositions and methods for mucositis and oncology therapies |
| 06/30/2011 | US20110158982 COMPOSITIONS AND METHODS FOR INHIBITING MAdCAM |
| 06/30/2011 | US20110158981 Methods and Compositions for Inhibiting Binding of IgE to a High Affinity Receptor |
| 06/30/2011 | US20110158980 Methods to treat and screen for agents to treat obesity |
| 06/30/2011 | US20110158979 Genetic component of complications in type 2 diabetes |
| 06/30/2011 | US20110158978 Ang-2 inhibition to treat multiple sclerosis |
| 06/30/2011 | US20110158977 Immunogenic compositions for Chlamydia trachomatis |
| 06/30/2011 | US20110158952 Compositions and methods for treating human papillomavirus-mediated disease |
| 06/30/2011 | US20110158940 Samll molecule inhibitors for the treatment or prevention of dengue virus infection |
| 06/30/2011 | US20110158910 Microparticles comprising polymers with thioester bonds |
| 06/30/2011 | US20110158908 Cyclosporin a-binding protein |
| 06/30/2011 | US20110158906 Targeted block copolymer micelles |
| 06/30/2011 | US20110158905 Dock-and-Lock (DNL) Complexes for Therapeutic and Diagnostic Use |
| 06/30/2011 | US20110158904 Antibodies that bind cell-associated ca 125/o772p and methods of use thereof |
| 06/30/2011 | US20110158902 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 06/30/2011 | CA2785585A1 Vaccine compositions |
| 06/30/2011 | CA2785414A1 Polypeptide modification method for purifying polypeptide multimers |
| 06/30/2011 | CA2785178A1 Anti-flt3 antibodies and methods of using the same |
| 06/30/2011 | CA2785139A1 Tetravalent cd47-antibody constant region fusion protein for use in therapy |
| 06/30/2011 | CA2784723A1 Non-fermented compositions comprising a cereal based fraction and a probiotic and uses thereof |
| 06/30/2011 | CA2784638A1 Streptavidin and biotin-based antigen delivery system |
| 06/30/2011 | CA2784447A1 Immunogenic compositions and related methods |
| 06/30/2011 | CA2784385A1 Anti-bv8 antibodies and uses thereof |
| 06/30/2011 | CA2784345A1 Antibodies to non-functional oligomeric p2x7 receptors |
| 06/30/2011 | CA2783955A1 Immunogenic compositions |
| 06/30/2011 | CA2783330A1 Herpes simplex virus vaccines |
| 06/30/2011 | CA2782571A1 Anti-her3 antibodies and uses thereof |
| 06/29/2011 | EP2339344A1 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 06/29/2011 | EP2339035A1 Endogenous retroviruses up-regulated in prostate cancer |
| 06/29/2011 | EP2339011A1 West Nile virus and Dengue 4 virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus |
| 06/29/2011 | EP2338984A1 Synthetic viruses and uses thereof |
| 06/29/2011 | EP2338915A2 Anti-VEGF antibodies |
| 06/29/2011 | EP2338914A1 Connective tissue growth factor antibodies |
| 06/29/2011 | EP2338907A1 Novel immunogenic epitopes for immunotherapy |
| 06/29/2011 | EP2338903A1 A canine vaccine for protection against ehrlichiosis |
| 06/29/2011 | EP2338902A1 Klebsiella antigens |
| 06/29/2011 | EP2338901A1 Replikin peptides and uses thereof |
| 06/29/2011 | EP2338894A1 Flavivirus fusion inhibitors |
| 06/29/2011 | EP2338517A1 Method for treatment or prevention of disease associated with functional disorder of regulatory T cell |
| 06/29/2011 | EP2338516A2 Multiple-variable dose regimen for treating TNF-alpha-related disorders |
| 06/29/2011 | EP2338515A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/29/2011 | EP2338514A1 Combined human IL-18 and pazopanib cancer treatment |
| 06/29/2011 | EP2338513A2 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 06/29/2011 | EP2338512A1 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| 06/29/2011 | EP2338511A2 Prolongation of survival of an allograft by inhibiting complement activity |
| 06/29/2011 | EP2338510A1 Vaccine compositions containing amyloid beta1-6 antigen arrays |
| 06/29/2011 | EP2338509A2 Method of selecting patients suitable for WT1 vaccine |
| 06/29/2011 | EP2338508A1 A rDEN3/4delta 30(ME), rDEN2/4delta30(ME) or rDEN1/4delta30(ME) recombinant chimeric dengue virus containing a 30 nucleotide deletion (delta30) in a section of the 3' untranslated region of dengue type 4 genome, wherein said 30 nucleotide deletion corresponds to the TL2 stem-loop structure. |
| 06/29/2011 | EP2338507A1 Method of treating malignancies through induction of blood immune responses |
| 06/29/2011 | EP2338506A2 Combinations of tumor-associated antigens for the treatment of various types of cancers |
| 06/29/2011 | EP2338498A1 Compositions for the inhibition of protein kinase C alpha for the treatment of diabetes mellitus |
| 06/29/2011 | EP2338055A2 Monoclonal antibodies for cspg4 for the diagnosis and treatment of basal breast carcinoma |
| 06/29/2011 | EP2337868A1 Detection of granulosa-cell tumors |
| 06/29/2011 | EP2337847A2 Vaccine adjuvants |
| 06/29/2011 | EP2337798A1 Bsa-specific antibodies |
| 06/29/2011 | EP2337795A2 Mhc multimers in cancer vaccines and immune monitoring |
| 06/29/2011 | EP2337789A2 Genus-wide chlamydial peptide vaccine antigens |
| 06/29/2011 | EP2337582A1 Bovine herpes virus -1 compositions, vaccines and methods |
| 06/29/2011 | EP2337581A1 Synthetic gene construct encoding an hiv-1 gag and the use thereof for obtaining anti-hiv-1 vaccines |
| 06/29/2011 | EP1981981B1 Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products |
| 06/29/2011 | EP1943359B1 Compositions and methods for il13 biomarkers |
| 06/29/2011 | EP1737493B1 Inhibitors of insulin-like growth factor receptor -1 for inhibiting tumor cell growth |
| 06/29/2011 | EP1658097B1 Nucleotide and cellular vaccine composition |
| 06/29/2011 | EP1576014B1 Antibodies against pd-1 and uses thereof |
| 06/29/2011 | EP1537147B9 Antibody anti hla-dr with an increased adcc and inducing cytokine production |
| 06/29/2011 | EP1523496B1 Recombinant production of mixtures of antibodies |
| 06/29/2011 | EP1520587B1 Allergy vaccine composition, production method thereof and use of same in allergy treatment |
| 06/29/2011 | EP1504036B1 Toxin-related fragments of antibodies with antimicrobial and antiviral activity |
| 06/29/2011 | EP1497321B1 Immunological methods and compositions for the treatment of alzheimer's disease |
| 06/29/2011 | EP1183348B1 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 06/29/2011 | CN1960750B Therapeutic use of anti-CS1 antibodies |
| 06/29/2011 | CN1842602B Modified vaccinia virus ankara (MVA) mutant and use thereof |
| 06/29/2011 | CN1835769B KIM-1 antagonists and use to modulate immune system |
| 06/29/2011 | CN1735430B 免疫原性组合物 The immunogenic composition |
| 06/29/2011 | CN1606565B Nucleic acids encoding recominant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 06/29/2011 | CN1427889B Hybrid cells obtainable from antigen presenting cells |
| 06/29/2011 | CN102112601A Novel fusion proteins and use thereof for preparing hepatitis c vaccines |
| 06/29/2011 | CN102112495A Dual variable domain immunoglobulins and uses thereof |
| 06/29/2011 | CN102112494A Dual variable domain immunoglobulins and uses thereof |
| 06/29/2011 | CN102112492A Diagnosis and treatment of cancer using anti-GPR49 antibody |
| 06/29/2011 | CN102112491A Anti-CD8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory CD8+t cells |
| 06/29/2011 | CN102112490A Notch1受体结合剂和其使用方法 Notch1 receptor binding agents and their use |
| 06/29/2011 | CN102112489A Anti-HEPCIDIN-25 selective antibodies and uses thereof |
| 06/29/2011 | CN102112155A Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases |
| 06/29/2011 | CN102112154A IL-1alpha abs and methods of use |
| 06/29/2011 | CN102112153A Use of inactivated japanese encephalitis virus particle as adjuvant |
| 06/29/2011 | CN102112152A Vaccine composition useful for HPV and hepatitis B infections and a method for preparing the same |
| 06/29/2011 | CN102112151A Microneedle device and method for increasing the response of japanese encephalitis virus antigen with the microneedle device |
| 06/29/2011 | CN102112150A Yeast strain for the production of proteins with terminal alpha-1, 3-linked galactose |
| 06/29/2011 | CN102112138A Anti-tumor agent |